Cardiovascular safety of tyrosine kinase inhibitors: Putting their “QT-phobia” in perspective. ADMET DMPK [Internet]. 2016 Oct. 1 [cited 2026 Jul. 31];4(3):212-31. Available from: https://pub.iapchem.org/ojs/index.php/admet/article/view/295